GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Inhibrx Biosciences INBX · USD

Health Care · US listing · 🇺🇸 United States

Compare

91.74

+8.54%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Inhibrx Biosciences and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
Inhibrx Biosciences INBX 91.74$1.33bn—-10773.5%— +8.54%
Septerna SEPN 50.74$2.25bn—-106.4%— +3.87%
Compass Therapeutics CMPX 0.84$148.9m—-5808.8%— +10.29%
MoonLake Immunotherapeutics MLTX 12.62$900.7m——— +9.45%
EyePoint EYPT 0.36$20.4m—-739.4%— +0.53%
InnovAge Holding INNV 9.21$1.25bn—-0.3%— +2.68%
Certara CERT 12.22$1.95bn—-0.4%— +1.41%
Savara SVRA 5.05$999.9m—-4301400.0%— +4.55%
Geron GERN 1.00$636.1m—-46.7%— +0.68%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.